Nervous system
|
Neuron derived exosomes
Schwan‐Cell derived exosomes
Microglia‐Cell derived exosomes
Astrocyte derived exosomes
Oligodendrocyte derived exosomes
|
Reciprocal control of excitatory synapse, modulation of axonal branching, neuronal activity and plasticity, release and trans‐synaptic transmission of proteins |
Spinal cord and peripheral nerve regeneration, targeted therapy for neurological disorders, early detection of neurodevelopmental disorders, neurodegenerative disorders, and traumatic brain injury |
Ultracentrifugation of neural cell culture medium, differential ultracentrifugation of brain tissue homogenates, and precipitation of cerebrospinal fluid |
17, 18, 19, 20, 21
|
Cardiovascular system
|
Cardiomyocyte derived exosomes
Cardiac Telocyte‐derived exosomes
Cardiac Progenitor‐Cell derived exosomes
Endothelial‐Cell derived exosomes
Cardiosphere‐derived exosomes
|
Induction of cardiomyocyte hypertrophy, regulation of oxidative stress and inflammation, inhibition of apoptosis, induction of cardiac endothelial cell proliferation, and modulation of cardiac fibrosis |
Biomarker of myocardial injury, targeted therapy for myocardial infarction and heart failure, and prognostic marker of cardiovascular diseases |
Differential ultracentrifugation of cardiomyocyte homogenates, multi‐step centrifugation of cardiac fibroblast culture medium, and precipitation of pericardial fluid |
6, 22, 23, 24
|
Liver
|
Hepatocyte derived exosomes
Cholangiocyte derived exosomes
Kupffer Cell‐derived exosomes
Liver Endothelial Cell‐derived exosomes
Hepatic Stellate Cell‐derived exosomes
|
Induction of hepatocyte survival, growth, migration and proliferation, trans‐differentiation of myofibroblast hepatic stellate cells, regulation of fibrosis, and the inflammatory response in the liver |
Targeted therapy for liver regeneration, biomarkers for assessing the safety of liver transplantation, diagnostic and prognostic markers of nonalcoholic fatty liver disease, and alcoholic liver disease |
Density‐gradient ultracentrifugation of liver tissue homogenates, differential ultracentrifugation, and precipitation of primary hepatocyte culture medium |
25, 26, 27, 28, 29
|
Stem cells
|
Mesenchymal Stem Cell‐derived exosomes
Neural Stem Cell‐derived exosomes
Induced Pluripotent Stem Cell‐derived exosomes
Embryonic Stem Cell‐derived exosomes
Endothelial Progenitor Cell‐derived exosomes
|
Development and growth of the embryo, adult tissue regeneration, differentiation and transformation, immunomodulation, and stromal remodeling |
Induction of tissue remodeling, targeted regenerative therapy for neoplasms, ischemic myocardium, graft‐versus‐host disease, memory dysfunction, autoimmune disorders, and other degenerative disorders |
Differential ultracentrifugation and one‐step sucrose cushion ultracentrifugation of stem cell culture medium, and precipitation from stem cell culture medium |
30, 31, 32, 33
|
Skeletal muscle
|
|
Control of myoblast differentiation and proliferation, regulation of skeletal muscle metabolic homeostasis, oxidative stress and inflammation |
Targeted therapy for muscular dystrophy, insulin resistance and other metabolic disorders affecting muscle physiology |
Differential ultracentrifugation of myoblast and myotube cell culture medium |
34, 35
|
Pancreas
|
|
Regulation of cell proliferation, migration and modulation of immune responses (regulation of chemokines expression in pancreatic cells, antigen deliver and activation of dendritic cells) |
Proposed as biomarkers for pancreatic cancer and as therapeutic target to control autoimmune responses in type‐1 diabetes |
Differential ultracentrifugation of cell culture medium |
36, 37, 38
|
Urinary exosomes
|
|
Induction of cell migration, modulation of angiogenesis, control of biological processes associated to the progression of advanced fibrotic disease, and regulation of inflammatory processes |
The exosome concentration and several exosomal miRNAs and proteins are proposed as biomarkers for bladder cancer, diabetic nephropathy, lupus nephritis, Parkinson's disease, IgA nephropathy, and prostate cancer |
Differential ultracentrifugation and precipitation of human urine |
39, 40, 41, 42, 43
|
Immune system
|
|
Antigens distribution and delivery for activation of immune response, elimination of immune cells for suppression of immune response, and regulation of the expression of pro‐inflammatory molecules |
Potential use as nanocarriers for the delivery of immunomodulatory molecules, and vaccines for immune therapy |
Differential ultracentrifugation and ultracentrifugation followed by sucrose gradient purification of culture medium |
44, 45, 46, 47, 48
|
Breast
|
|
Regulation of immune response, protective role against vertical transmission of HIV‐1, and stimulation of intestinal stem cell activity |
Prevention of necrotizing enterocolitis in intolerant breastfeeding infants and immune therapy |
Differential centrifugation of human breast milk of healthy mothers and precipitation of human and rat breast milk |
49, 50, 51, 52
|
Tumor‐derived exosomes
|
Glioblastoma cell‐derived exosomes
Colon cancer cell‐derived exosomes
Melanoma cell‐derived exosomes
Nasopharyngeal carcinoma cell‐derived exosomes
Prostate cancer cell‐derived exosomes
Cervical cancer cell‐derived exosomes
Diffuse large B‐cell lymphoma side population cell‐derived exosomes
Lung cancer cell‐derived exosomes
Bladder cancer cell‐derived exosomes
Breast cancer‐cell derived exosomes
Mesothelioma cancer cell‐derived exosomes
Pancreatic cancer cell‐derived exosomes
Renal cancer cell‐derived exosomes
Chronic myeloid leukemia cell‐derived exosomes
Hepatocellular carcinoma cell‐derived exosomes
|
Promotion of tumor proliferation, invasion and metastasis, enhance angiogenesis, impair immune response and increase cancer resistance to therapies |
Proposed as biomarkers for the detection of several types of cancer and nanocarriers for targeted drug delivery against cancer proliferation |
Differential centrifugation and precipitation of human fluids and cell culture medium |
53, 54
|